BBLG
Bone Biologics CorpCompany with tickers: BBLG, BBLGW
CIK
1419554
CUSIP
098070600
Shares Outstanding
1,795,260
13F Activity (30d)
2 filings
2 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $805,054 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Research & Development | $141,597 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Operating Income | $-805,054 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Net Income | $-765,988 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Basic) | $-0.43 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Diluted) | $-0.43 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |